sing Mobile applications studying the patient medication compliance to Cardiovascular drugs.

Not Applicable

• Conditions: Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere

• Registration Number: CTRI/2023/04/051649
• Lead Sponsor: Kamaleswari

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Both male and female patients above 18 years.

2.Cardiac Patient who underwent Interventional and or surgical procedures and preferred medical therapy, were included in the study.

3.Patients prescribed at least 1 cardiovascular medication, which may have include antihypertensives (β-blockers, calcium antagonists, diuretics, angiotensin converting enzyme inhibitors, and angiotensin II receptor antagonists), antihyperlipidemics (statins), or anticoagulants (direct-acting oral anticoagulants).

Exclusion Criteria

1.Patients with co-morbid conditions such as chronic liver and kidney diseases, chronic obstructive pulmonary diseases, malignancy, and collagen vascular diseases were excluded from the study.

2.Patients who were not able to give written informed consent will be excluded.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage reduction in cardiovascular events, adherence rate and overall long-term health and well-being.Timepoint: weekly, 6m and 1 year followup

Secondary Outcome Measures

Name	Time	Method
ILTimepoint: NI